Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

As of September 30, 2015, a total of 1589 laboratory-confirmed cases of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to the World Health Organization (WHO). At present there is no effective specific therapy against MERS-CoV. The use of convalescent pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabi, Yaseen, Balkhy, Hanan, Hajeer, Ali H., Bouchama, Abderrezak, Hayden, Frederick G., Al-Omari, Awad, Al-Hameed, Fahad M., Taha, Yusri, Shindo, Nahoko, Whitehead, John, Merson, Laura, AlJohani, Sameera, Al-Khairy, Khalid, Carson, Gail, Luke, Thomas C., Hensley, Lisa, Al-Dawood, Abdulaziz, Al-Qahtani, Saad, Modjarrad, Kayvon, Sadat, Musharaf, Rohde, Gernot, Leport, Catherine, Fowler, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653124/
https://www.ncbi.nlm.nih.gov/pubmed/26618098
http://dx.doi.org/10.1186/s40064-015-1490-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653124/
https://www.ncbi.nlm.nih.gov/pubmed/26618098
http://dx.doi.org/10.1186/s40064-015-1490-9

Ejemplares similares